
Explore the fundamentals of vaccine pharmacovigilance, including Brighton collaboration criteria, AEFI, vaccination failure, data collection, analysis, and safety signal management across four modules.
Learn how vaccines build active immunity by exposing the body to antigenic components, examine inactivated, live attenuated, mRNA, subunit and other vaccine types, and review pharmacovigilance and Brighton Collaboration.
Explains why vaccine pharmacovigilance differs from drug pharmacovigilance by outlining complex information capture for vaccines with antigens, live organisms, adjuvants, preservatives, and distinct causality assessment and reporting chains.
Learn why vaccine safety monitoring matters by weighing adverse events against vaccine benefits and applying the first do no harm principle to risk–benefit assessments.
Explore key elements of vaccine pharmacovigilance, including subpopulations at risk, serious and nonserious adverse events, causal assessment methods, concomitant vaccine administration, batch information, and herd immunity.
Define adverse events following immunization (aefi) and classify them within vaccine pharmacovigilance into vaccine product related, quality defect related, immunization error related, immunization anxiety related, and coincidental events.
Identify and apply the vaccination failure algorithm to distinguish failure to vaccinate from vaccine failure, evaluate compliance, storage, and program issues, and use confirmatory testing to classify outcomes.
Learn how to collect, analyze, and present vaccine safety data by identifying key elements: identifiable reporter, identifiable patient, prior immunizations, and detailed adverse event descriptions.
Analyze data after collection by classifying reported adverse events following immunization into cases meeting or not meeting the Brighton Collaboration case definition, using diagnostic certainty levels.
present adverse events following immunization data per guidelines, with numerator and denominator, validated case definitions, and methods for data collection, surveillance type, and suitable descriptive statistics.
Explore how the adverse event following immunization (aefi) report form captures reporter and patient details, vaccine data, onset timing, and treatment for thorough pharmacovigilance.
Title: Vaccine Pharmacovigilance Certificate Course
______________________________________________________________________________________________________
Ensuring Vaccine Safety for Public Health.
Are you interested in playing a crucial role in safeguarding public health through vaccine safety? Enroll in our specialized course, "Vaccine Pharmacovigilance [Vaccinovigilance]" to gain the knowledge and skills needed to monitor and assess the safety of vaccines.
Key Highlights:
Basics of Vaccines and Vaccine Pharmacovigilance
Brighton Collaboration criteria
Adverse events following immunization [AEFI]
How PV of Vaccines is different from other drugs
Why Vaccine Safety Monitoring is required
Elements to consider in Vaccine PV
Collection, Analysis and Presentation of Vaccine safety data
Differences between Vaccines and Drugs in signal detection
Why Choose This Course?
Specialized Knowledge: Vaccine pharmacovigilance is a specialized field with growing importance. Equip yourself with the knowledge and skills needed to excel in this critical area of public health.
Career Advancement: Enhance your career prospects in public health, pharmacovigilance, or regulatory affairs. Gain a competitive edge with expertise in vaccine safety.
Impactful Contribution: Make a meaningful contribution to public health by ensuring the safety and efficacy of vaccines. Your work in vaccine pharmacovigilance can help save lives and prevent diseases.
Who Should Enroll:
Pharmacovigilance Professionals
Public Health Professionals
Pharmacists
Healthcare Workers
Regulatory Affairs Professionals
Anyone interested in vaccine safety and public health
Don't miss this opportunity to become a key player in vaccine safety. Enroll now and embark on a rewarding journey to protect public health through vaccine pharmacovigilance [Vaccinovigilance]!
Note: Basic knowledge of pharmacovigilance and vaccines is recommended but not required.